Trial Profile
Contrast Enhanced Ultrasound Evaluation of Brain Perfusion in Neonatal Post-Hemorrhagic Hydrocephalus
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 29 Jan 2018
Price :
$35
*
At a glance
- Drugs Sulfur hexafluoride (Primary)
- Indications Hydrocephalus
- Focus Pharmacokinetics
- 22 Jan 2018 Status changed from not yet recruiting to withdrawn prior to enrolment as PI is leaving the institution
- 15 Mar 2017 Planned initiation date changed from 1 Mar 2017 to 1 Apr 2017.
- 02 Mar 2017 New trial record